wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34645665-68C91CB8-A5DB-4D2C-BE71-D88593606AFD
Q34645665-68C91CB8-A5DB-4D2C-BE71-D88593606AFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34645665-68C91CB8-A5DB-4D2C-BE71-D88593606AFD
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
P2860
Q34645665-68C91CB8-A5DB-4D2C-BE71-D88593606AFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34645665-68C91CB8-A5DB-4D2C-BE71-D88593606AFD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eea1e4a20787b19be76b9fcb874f2f475c806843
P2860
Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.